[EN] IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS [FR] DÉRIVÉS D'IMINOTÉTRAHYDROPYRIMIDINONE UTILISÉS COMME INHIBITEURS DE PLASMEPSINE V
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors
申请人:UCB Biopharma SPRL
公开号:US11136310B2
公开(公告)日:2021-10-05
A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
一系列 2-亚氨基-6-甲基四氢嘧啶-4(1H)-酮衍生物,在 6 位被苯基取代,而苯基又被含有至少一个氮原子的任选取代的不饱和融合双环体系元取代,是胰蛋白酶 V 活性的选择性抑制剂,可用作药物,特别是治疗疟疾。
IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS
申请人:UCB Biopharma SPRL
公开号:EP3380464A1
公开(公告)日:2018-10-03
WO2023/225558
申请人:——
公开号:——
公开(公告)日:——
[EN] IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS<br/>[FR] DÉRIVÉS D'IMINOTÉTRAHYDROPYRIMIDINONE UTILISÉS COMME INHIBITEURS DE PLASMEPSINE V
申请人:UCB BIOPHARMA SPRL
公开号:WO2017089453A1
公开(公告)日:2017-06-01
A series of 2-imino-6-methyltetrahydropyrimidin-4(lH)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.